Fidelity Disruptive Medicine Fund - Loyalty Class 2
$11.61
Fidelity Disruptive Medicine Fund - Loyalty Class 2 (FRXMX) Forecast
See the Price Targets and Ratings of:
FRXMX Analyst Rating
Moderate Buy
67ConsensusRatings
48Buy18Hold1Sell
Based on the Wall Street analyst consensus for 67 of FRXMX’s holdings.
FRXMX Analyst Price Target
Average Price Target
$14.12▲(21.60% Upside)
Based on Wall Street analyst 12-month price targets for 67 of Fidelity Disruptive Medicine Fund - Loyalty Class 2’s holdings in the last 3 months. The average price target is $14.12 with a high forecast of $17.13 and a low forecast of $11.34. The average price target represents a 21.60% change from the last price of $11.61.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$17.13
Average$14.12
Low$11.34
Past 12 Months12 Month Forecast$10$12$14$16$18Feb2026May2026Aug2026Nov2026Nov2027
What is FRXMX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 67 of FRXMX’s holdings, Fidelity Disruptive Medicine Fund - Loyalty Class 2’s 12-month average price target is $14.12.
What is FRXMX’s upside potential, based on the analysts’ average price target?
FRXMX’s average price target of $14.12 represents a 21.60% upside from its last price of $11.61.
Is FRXMX a Buy, Sell or Hold?
Fidelity Disruptive Medicine Fund - Loyalty Class 2 has a consensus rating of Moderate Buy, based on the analyst consensus for 67 of FRXMX’s holdings: 48 rated Buy, 18 rated Hold and 1 rated Sell.
What is Fidelity Disruptive Medicine Fund - Loyalty Class 2’s price target?
The average price target for Fidelity Disruptive Medicine Fund - Loyalty Class 2 is $14.12, based on Wall Street analyst 12-month price targets for 67 of FRXMX’s holdings, issued in the past 3 months. The highest price target is $17.13 and the lowest is $11.34. The average price target represents a 21.60% increase from the last price of $11.61.
How can I buy shares of FRXMX?
You can buy shares of FRXMX through a brokerage account. Compare brokers on our Best Online Brokers page.